Drugs / GSK223192A
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00805389 | Dec 2008 → Sep 2010 | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK223192A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00805389 ↗ |
| Modality | Vaccine | “GSK Biologicals' Hepatitis B vaccines (GSK223192A)” NCT00805389 ↗ |